r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

JL

John M. Leonard

Insider · President and CEO · NTLA

John M. Leonard files insider transactions with the SEC as a president and ceo of Intellia Therapeutics (NTLA). We hold 3 disclosed purchases and sales filed since 19 February 2013, 2 of them in the last 90 days.

  • Files forNTLA
  • Disclosed buys and sells3 in all, 2 in the last 90 days
  • Last disclosure24 August 2026

Positions held

6 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 6 January 2017 — 21 August 2026President and CEO · Intellia Therapeutics (NTLA)155 Form 4 lines · source: SEC Form 4
  • Filed 26 April 2018 — 23 April 2026Director · Iqvia Holdings (IQV)17 Form 4 lines · source: SEC Form 4
  • Filed 20 June 2014 — 28 June 2017Director · Chimerix (CMRX)8 Form 4 lines · source: SEC Form 4
  • Filed 4 March 2015 — 23 May 2017Director · Quintiles Transnational Holdings (Q)7 Form 4 lines · source: SEC Form 4
  • Filed 29 July 2015 — 25 October 2016Director · Vitae Pharmaceuticals (VTAE)4 Form 4 lines · source: SEC Form 4
  • Filed 14 February 2013 — 15 March 2013SVP, Chief Scientific Officer · AbbVie (ABBV)12 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.